Skip to Main Content

Paper Details

Use of real-world evidence data to evaluate the comparative effectiveness of second-line type 2 diabetes medications on chronic kidney disease.
J Clin Transl Endocrinol
1
2022
Author NameAffiliation
Lihui ZhaoFeinberg School of Medicine, Northwestern University
Abel N KhoCenter for Health Information Partnerships, Feinberg School of Medicine, Northwestern University
  • 1 - 2

Datasets

Release 1.2